These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16157568)
1. Inactivation of the BSE agent by the heat and pressure process for manufacturing gelatine. Grobben AH; Steele PJ; Somerville RA; Taylor DM; Schreuder BE Vet Rec; 2005 Sep; 157(10):277-81. PubMed ID: 16157568 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of BSE infectivity on chips of bone by autoclaving during the manufacture of gelatine. Grobben AH; Steele PJ; Somerville RA; Taylor DM Vet Rec; 2006 Jan; 158(3):94-6. PubMed ID: 16428664 [No Abstract] [Full Text] [Related]
3. Inactivation of transmissible spongiform encephalopathy agents during the manufacture of dicalcium phosphate from bone. Grobben AH; Steele PJ; Somerville RA; Taylor DM Vet Rec; 2006 Mar; 158(11):361-6. PubMed ID: 16547182 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of the bovine-spongiform-encephalopathy (BSE) agent by the acid and alkaline processes used in the manufacture of bone gelatine. Grobben AH; Steele PJ; Somerville RA; Taylor DM Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):329-38. PubMed ID: 15154846 [TBL] [Abstract][Full Text] [Related]
5. Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Taylor DM Clin Microbiol Infect; 2002 Jun; 8(6):332-9. PubMed ID: 12084100 [TBL] [Abstract][Full Text] [Related]
7. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177 [TBL] [Abstract][Full Text] [Related]
9. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Scott MR; Will R; Ironside J; Nguyen HO; Tremblay P; DeArmond SJ; Prusiner SB Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15137-42. PubMed ID: 10611351 [TBL] [Abstract][Full Text] [Related]
10. Detection of PrPres in peripheral tissue in pigs with clinical disease induced by intracerebral challenge with sheep-passaged bovine spongiform encephalopathy agent. Hedman C; Otero A; Douet JY; Lacroux C; Lugan S; Filali H; Corbière F; Aron N; Badiola JJ; Andréoletti O; Bolea R PLoS One; 2018; 13(7):e0199914. PubMed ID: 29975760 [TBL] [Abstract][Full Text] [Related]
11. Gelatine production, the six steps to maximum safety. Schrieber R; Seybold U Dev Biol Stand; 1993; 80():195-8. PubMed ID: 8270109 [TBL] [Abstract][Full Text] [Related]
12. Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Reichl HE; Foster PR; Welch AG; Li Q; MacGregor IR; Somerville RA; Fernie K; Steele PJ; Taylor DM Vox Sang; 2002 Aug; 83(2):137-45. PubMed ID: 12201843 [TBL] [Abstract][Full Text] [Related]
13. Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice. Jaumain E; Quadrio I; Herzog L; Reine F; Rezaei H; Andréoletti O; Laude H; Perret-Liaudet A; Haïk S; Béringue V J Virol; 2016 Dec; 90(23):10867-10874. PubMed ID: 27681129 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of the BSE agent. Taylor D C R Biol; 2002 Jan; 325(1):75-6. PubMed ID: 11862625 [TBL] [Abstract][Full Text] [Related]
15. Consumption of bovine spongiform encephalopathy (BSE) contaminated beef and the risk of variant Creutzfeldt-Jakob disease. Chen CC; Wang YH; Wu KY Risk Anal; 2013 Nov; 33(11):1958-68. PubMed ID: 23755826 [TBL] [Abstract][Full Text] [Related]
16. [Bovine spongiform encephalopathy in ruminants and the new variant of Creutzfeldt-Jakob disease in humans]. Groschup MH Dtsch Tierarztl Wochenschr; 1999 Aug; 106(8):329-31. PubMed ID: 10488637 [TBL] [Abstract][Full Text] [Related]
17. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Bruce ME; Will RG; Ironside JW; McConnell I; Drummond D; Suttie A; McCardle L; Chree A; Hope J; Birkett C; Cousens S; Fraser H; Bostock CJ Nature; 1997 Oct; 389(6650):498-501. PubMed ID: 9333239 [TBL] [Abstract][Full Text] [Related]
18. Transmission barriers for bovine, ovine, and human prions in transgenic mice. Scott MR; Peretz D; Nguyen HO; Dearmond SJ; Prusiner SB J Virol; 2005 May; 79(9):5259-71. PubMed ID: 15827140 [TBL] [Abstract][Full Text] [Related]
19. Unique properties of the classical bovine spongiform encephalopathy strain and its emergence from H-type bovine spongiform encephalopathy substantiated by VM transmission studies. Bencsik A; Leboidre M; Debeer S; Aufauvre C; Baron T J Neuropathol Exp Neurol; 2013 Mar; 72(3):211-8. PubMed ID: 23399901 [TBL] [Abstract][Full Text] [Related]